CELLSCRIPT Employee Directory
Biotechnology ResearchWisconsin, United States11-50 Employees
CELLSCRIPT develops and supplies products and technologies that enable the production and use of RNA for translation in cells, supporting clinical research and therapeutic development. Its offerings include tools to generate RNA in a controlled setting, add 5' caps, and polyadenylate RNA, including constructs with modified nucleosides such as pseudouridine licensed from the University of Pennsylvania. These capabilities help researchers design and test RNA constructs for use in cellular systems and potential in vivo studies. Based in Madison, Wisconsin, CELLSCRIPT operates in the biotechnology research sector. Its customers are biotechnology and pharmaceutical researchers pursuing RNA-based approaches for clinical research and therapeutics, and the company has engaged in partnerships such as a 2017 licensing agreement with BioNTech covering nucleoside-modified mRNA for in vivo applications. This history illustrates the firm's role as a provider of RNA tools and related intellectual property to support in vivo and therapeutic research pipelines.